US FDA approves Citius therapy to treat rare blood cancer
The U.S. Food and Drug Administration has approved a drug Citius Pharmaceuticals company said Thursday is a therapy for patients with a form of blood cancer who have already undergone at least one course of treatment, a year after the regulator rejected it.
ENTRADAS POPULARES
Thousands under evacuation orders in California due to wildfires
noviembre 8, 2024
EU scientists say 2024 will be the hottest year on record
noviembre 8, 2024
TRANSMISIÓN EN VIVO